Suzuken Co., Ltd.

Research Suzuken Co., Ltd. (9987.T) on Bullrun: market cap JPY 360.43B, P/E 10.2, dividend yield 3.2%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is JPY 360.43B; P/E is 10.2; dividend yield is 3.2%.

Peer valuation comparison

Latest P/E is 10.24x versus a Healthcare sector median of 21.69x (52.8% below).

Latest dividend yield is 3.15% versus a Healthcare sector median of 2.41% (30.7% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2026JPY 2.49TJPY 38.14BJPY 15.72B7.7%545.54JPY 116.70Bn/aJPY 415.88B
FY2025JPY 2.40TJPY 34.50B-JPY 83.73B8.0%454.58JPY 102.66Bn/aJPY 407.29B
FY2024JPY 2.39TJPY 29.02BJPY 71.58B7.8%357.88JPY 181.83Bn/aJPY 416.31B
FY2023JPY 2.31TJPY 20.35BJPY 19.53B7.8%236.47JPY 109.03Bn/aJPY 411.21B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18JPY 360.43B10.22.2%60

Dividend history

Latest trailing dividend snapshot: annual dividend/share 60 JPY, yield 3.2%.

YearDividends/share
FY202685 JPY
FY202550 JPY
FY202445 JPY
FY202338 JPY

About Suzuken Co., Ltd.

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Healthcare Product Development, Community Healthcare and Nursing Care Support, Specialty Drug Contract Distribution, and Healthcare Related Services.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Suzuken Co., Ltd.'s market cap?

Suzuken Co., Ltd.'s market capitalization is JPY 360.43B.

What is Suzuken Co., Ltd.'s P/E ratio?

Suzuken Co., Ltd.'s price-to-earnings (P/E) ratio is 10.2.

Does Suzuken Co., Ltd. pay a dividend?

Suzuken Co., Ltd. has a dividend yield of 3.2%.

What does Suzuken Co., Ltd. do?

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Healthcare Product Development, Community Healthcare and Nursing Care Support, Specialty Drug Contract Distribution, and Healthcare Related Services.